Top Reasons to Consider PRRT for Neuroendocrine Tumor Treatment in Israel
Why People Are Coming to Israel for PRRT to Treat Neuroendocrine Tumors
Peptide Receptor Radionuclide Therapy (PRRT) is a molecular targeted therapy used to treat neuroendocrine tumors (NETs). Over the last decade, this innovative treatment has been used to improve the prognoses of NET patients in Europe. It is now available at Sheba Medical Center in Israel.

Request a consultation
Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.
We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.
Request a consultation and a Sheba Case Manager will contact you shortly: